Literature DB >> 2547772

Immunological identification of 1,25-dihydroxyvitamin D3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation.

Y Lee1, M Inaba, H F DeLuca, W S Mellon.   

Abstract

Immunological techniques were utilized to detect 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) receptor levels and to characterize physical/chemical changes in receptors in human promyelocytic leukemic cells (HL-60) during continuous exposure to hormone. The monoclonal antibody (IVG8C11) raised against the porcine intestinal 1,25-(OH)2D3 receptor immunoprecipitated quantitatively 1,25-(OH)2D3 receptors in nuclear extracts from HL-60 cells. The highly enriched immunoprecipitated receptors were electrophoresed on sodium dodecyl sulfate-polyacrylamide gels and transferred to polyvinylidene difluoride membranes, which were probed with 125I-labeled IVG8C11. The basal receptor from the cells treated with 1,25-(OH)2D3 for 2 h was detected as a single form at 53 kDa. Moreover, receptors were shown to be up-regulated at 12 h and down-regulated at 48 and 72 h in the continuous presence of hormone as evidenced by the ratio of density of the bands, 1.0 (2 h):4.2 (12 h):1.2 (48 h):0.9 (72 h), as measured by laser scanning densitometry. The up- and down-regulated receptors were also detected as single forms and had the same molecular mass as the basal receptor. Therefore, the data presented here strongly support the hypothesis of homologous regulation of 1,25-(OH)2D3 receptors in intact human target cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547772

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

Authors:  T Naveh-Many; R Marx; E Keshet; J W Pike; J Silver
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 2.  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Authors:  S Christakos; M Raval-Pandya; R P Wernyj; W Yang
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

3.  1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.

Authors:  Seiichi Ishizuka; Noriyoshi Kurihara; Yuko Hiruma; Daishiro Miura; Jun-ichi Namekawa; Azusa Tamura; Yuko Kato-Nakamura; Yusuke Nakano; Kazuya Takenouchi; Yuichi Hashimoto; Kazuo Nagasawa; G David Roodman
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-22       Impact factor: 4.292

4.  1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo.

Authors:  M Strom; M E Sandgren; T A Brown; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 5.  Inhibitors for the Vitamin D Receptor-Coregulator Interaction.

Authors:  Kelly A Teske; Olivia Yu; Leggy A Arnold
Journal:  Vitam Horm       Date:  2015-11-30       Impact factor: 3.421

6.  Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma.

Authors:  Christoph Renné; Alexander H Benz; Martin L Hansmann
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

7.  The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.

Authors:  T Hickish; D Cunningham; K Colston; B C Millar; J Sandle; A G Mackay; M Soukop; J Sloane
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.